Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
07/2000
07/05/2000CN1259132A Compounds
07/05/2000CN1259131A Compounds
07/05/2000CN1258673A New imidazole derivate and its producing process
07/05/2000CN1054046C Lycopodium clavatus injecta and its preparing method
07/05/2000CN1054044C Chinese herb medicine tablet for treating bronchitis and its producing process
07/05/2000CA2293928A1 A novel substituted alkyltetraamine derivative
07/04/2000US6084083 Amino acid sequence of polypeptide; for prognosis, diagnosis, monitoring, rational drug design, and/or therapeutic intervention of t helper cell related disorders including crohn's disease, lyme disease, insulin-dependent diabetes
07/04/2000US6084075 Agonist and antagonist antibodies to the chemokine receptor-2 (CCR2)
07/04/2000US6083993 Method for treating bronchospasm using optically pure R(-) albuterol
07/04/2000US6083974 Benzothiophenecarboxamide derivatives and PGD2 antagonists comprising them
07/04/2000US6083973 Methods for inhibiting mucin secretion using RAR α selective antagonists
07/04/2000US6083960 Constrained somatostatin agonists and antagonists
07/04/2000US6083957 Heterocyclic compounds and their preparation and use
07/04/2000US6083954 Method of treating cystic fibrosis
07/04/2000US6083952 Compounds
07/04/2000US6083951 Aryl-substituted pyrimidine sulphonamide compounds as endothelin antagonists
07/04/2000US6083944 Enzyme inhibitors; treatment of various debilitating disorders
07/04/2000US6083936 Treatment of estrogen-dependent disorders such as estrogen-dependent cancers; also useful in diagnostic techniques such as magnetic resonance imaging and magnetic resonance spectroscopy
07/04/2000US6083926 Water soluble vitamin B12 receptor modulating agents and methods related thereto
07/04/2000US6083925 Nucleic acid respiratory syncytial virus vaccines
07/04/2000US6083922 Method and a tobramycin aerosol formulation for treatment prevention and containment of tuberculosis
07/04/2000US6083903 Boronic ester and acid compounds, synthesis and uses
07/04/2000CA2116565C Low speed model following velocity command system for rotary wing aircraft
07/04/2000CA2025212C (2-imidazolin-2-ylamino) tetrahydroquinoxalines and methods for using same
07/04/2000CA1341044C Benzopyrido piperidine, piperidylidene and peperazine compounds, compositions, methods of manufacture and methods of use
06/2000
06/29/2000WO2000037944A1 Kidney disease detection and treatment
06/29/2000WO2000037639A2 Lymphocytic membrane proteins
06/29/2000WO2000037502A2 Vascular endothelial cell growth factor antagonists and uses thereof
06/29/2000WO2000037474A1 Fused 1,2,4-thiadiazine derivatives, their preparation and use
06/29/2000WO2000037472A2 Substituted pirroloindoles
06/29/2000WO2000037470A1 Antihistaminic spiro compounds
06/29/2000WO2000037462A1 Non-peptide nk1 receptors antagonists
06/29/2000WO2000037451A1 Il-5 inhibiting 6-azauracil derivatives
06/29/2000WO2000037444A1 Compounds useful in the treatment of inflammatory diseases
06/29/2000WO2000037436A1 Sulfonamide hydroxamates
06/29/2000WO2000037429A2 INHIBITORS OF α4β1 MEDIATED CELL ADHESION
06/29/2000WO2000037422A2 Ion channel modulating agents
06/29/2000WO2000037358A1 NOVEL sPLA2 INHIBITORS
06/29/2000WO2000037107A2 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia
06/29/2000WO2000037099A2 Method for accelerating the rate of mucociliary clearance by using a kunitz-type serine protease inhibitor
06/29/2000WO2000037094A2 Therapeutic applications of flint polypeptides
06/29/2000WO2000037090A1 Medicaments for the treatment of lung infections
06/29/2000WO2000037088A1 Use of etherlysophospholipids as antiinflammatory agents
06/29/2000WO2000037073A1 Use of 5ht3-receptor antagonists for the treatment of chronic fatigue syndrome
06/29/2000WO2000037068A1 Use of a 5ht2a and 5ht2a/c receptor antagonist for preparing medicines for treating snoring and high resistance syndrome of upper anatomical airways
06/29/2000WO2000037044A1 Soft and chewy cough and cold relief composition
06/29/2000WO2000037025A2 Antibodies to truncated vegf-d and uses thereof
06/29/2000WO2000036915A1 Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs
06/29/2000WO2000012497A3 Quinazoline derivatives as medicaments
06/29/2000WO2000002543A3 Antihypersensitive combination of valsartan and calcium channel blocker
06/29/2000WO1999064034A9 β2-ADRENERGIC RECEPTOR AGONISTS
06/29/2000CA2358508A1 Therapeutic applications of flint polypeptides
06/29/2000CA2356736A1 Use of etherlysophospholipids as antiinflammatory agents
06/29/2000CA2356426A1 Method of using a cyclooxygenase-2 inhibitor and a matrix metalloproteinase inhibitor as a combination therapy in the treatment of neoplasia
06/29/2000CA2356246A1 Use of 5ht3-receptor antagonists for the treatment of chronic fatigue syndrome
06/29/2000CA2356174A1 Kidney disease detection and treatment
06/29/2000CA2356162A1 Substituted tricyclics
06/29/2000CA2356159A1 Novel spla2 inhibitors
06/29/2000CA2355902A1 Sulfonamide hydroxamates
06/29/2000CA2355896A1 Antibodies to truncated vegf-d and uses thereof
06/29/2000CA2355630A1 Compounds useful in the treatment of inflammatory diseases
06/29/2000CA2355137A1 Non-peptide nk1 receptors antagonists
06/29/2000CA2355074A1 Lymphocytic membrane proteins
06/29/2000CA2354511A1 Il-5 inhibiting 6-azauracil derivatives
06/29/2000CA2353907A1 Fused 1,2,4-thiadiazine derivatives, their preparation and use
06/29/2000CA2351674A1 Use of a 5ht2a and 5ht2a/c receptor antagonist for preparing medicines for treating snoring and high resistance syndrome of upper anatomical airways
06/28/2000EP1013760A2 Stable bactericidal/permeabilityincreasing protein products and pharmaceutical compositions containing the same
06/28/2000EP1013284A2 Purified forms of dnase
06/28/2000EP1013276A1 Aminoazacycloalkanes as CCR5 modulators
06/28/2000EP1013275A2 Method and compositions for treating hypertension, angina and other disorders using optically pure (-) amlodipine
06/28/2000EP1012321A2 Viral infection of cells using viral vectors
06/28/2000EP1012292A1 Ntn-2 member of tnf ligand family
06/28/2000EP1012281A2 Human leukocyte calcium activated potassium channel polypeptide
06/28/2000EP1012278A1 Murine and human cerberus-like proteins and compositions comprising them
06/28/2000EP1012266A1 Galectin 8, 9, 10 and 10sv
06/28/2000EP1012242A1 Human sigma receptor
06/28/2000EP1012154A2 Salts of di(uridine 5'-tetraphosphate), method for preparation and uses thereof
06/28/2000EP1011725A1 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
06/28/2000EP1011709A1 Inhibition of apoptotis using prosaposin receptor agonists
06/28/2000EP1011688A1 Use of uridine 5'-diphosphate and analogs thereof for the treatment of lung diseases
06/28/2000EP1011686A1 Modulation of human mast cell activation
06/28/2000EP1011677A1 4-aryl-3-aminoquinoline-2-one derivatives as potassium channel modulators
06/28/2000EP1011664A1 8a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS
06/28/2000EP1011663A1 BETA-LACTAM INHIBITORS OF CoA-IT
06/28/2000EP1011637A1 Modulation of drug loading in multivesicular liposomes
06/28/2000EP1011607A2 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
06/28/2000CN1258296A Pyridine derivatives and pharmaceutical compositions contg. them
06/28/2000CN1258219A Benzocycloheptathiophene compounds
06/28/2000CN1257709A Chinese medicine
06/28/2000CN1053835C 'Qinbiaohong' cough-relieving capsule and its preparing method
06/28/2000CN1053816C Oily preparation for treating rhinitis and its preparing process
06/28/2000CN1053814C Medicinal liquid for treating rhinitis and preparing method thereof
06/28/2000CN1053809C Compound preparation for throat diseases
06/27/2000US6080878 Method of preparing 16-dehydro vitamin D compounds
06/27/2000US6080869 Chemical reduction process; forming dopamine da2 receptor agonists and beta2 adrenoreceptor agonists for treating obstructive airways diseases
06/27/2000US6080774 Substituted biphenylsulfonamide endothelin antagonists
06/27/2000US6080766 Method for the treatment of fibroproliferative disorders by application of inhibitors of protein hydroxylation
06/27/2000US6080758 Analgesics, antiinflammatory agents; asthma; allergic rhinitis
06/27/2000US6080740 Spiro-ketal derivatives and their use as therapeutic agents
06/27/2000CA2198564C Method of reducing tissue damage associated with non-cardiac ischemia
1 ... 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 ... 878